Skip to content

EV / EBITDA at other companies

AbbVie logo
AbbVieABBV
19.8×
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
42.4×
Lifevantage Corporation logo
Lifevantage CorporationLFVN
5.6×-5.1×
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
25.6×
NuSkin Enterprises logo
NuSkin EnterprisesNUS
3.5×
Kenvue logo
KenvueKVUE
12.8×-9.3×

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-63.3%
Enterprise value$11.24M-97.3%
P/S0.3×-0.5×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Calculated from The Beauty Health Company’s reported figures.

Based on the most recent quarter.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's EV / EBITDA?
The Beauty Health Company (SKIN) reported EV / EBITDA of 3.8× in Q1 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.